Search

Displaying results 7391 - 7400 of 10000 in total
  1. Drug

    Neracorvir

    go.drugbank.com/drugs/DB21630
    Experimental

    The usage of the INN stem '-corvir' in the name indicates that Neracorvir is a core protein (Cp) inhibitor. Neracorvir has a monoisotopic molecular weight of 419.12 Da.

  2. Drug

    Tacaciclib

    go.drugbank.com/drugs/DB21644
    Experimental

    The usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor. Tacaciclib has a monoisotopic molecular weight of 528.28 Da.

  3. Drug

    Fovinaciclib

    go.drugbank.com/drugs/DB21721
    Investigational

    The usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor. Fovinaciclib has a monoisotopic molecular weight of 548.3 Da.

  4. Drug

    Zeprumetostat

    go.drugbank.com/drugs/DB21740
    Investigational

    The usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor. Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.

  5. Drug

    Nadifloxacin

    go.drugbank.com/drugs/DB12447
    Investigational

    Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris.

  6. Drug

    Peptide YY (3-36)

    go.drugbank.com/drugs/DB05004
    Investigational

    Peptide YY (3-36), a synthetic human PYY 3-36, is a compound being evaluated for the treatment of obesity. It reduces appetite and increases satiety in obese patients.

  7. Drug

    Crefmirlimab

    go.drugbank.com/drugs/DB17577
    Investigational

    Crefmirlimab is an anti-human CD8 probe targeting the CD8 antigen, for the diagnosis of various cancers.

    Synonyms: Iab22m2c (antibody fragment against the human cd8-antigen on cd8-positive t-cells)
  8. Drug

    Arundic acid

    go.drugbank.com/drugs/DB05343
    Investigational

    Arundic acid has been investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).

  9. Drug

    NGD-4715

    go.drugbank.com/drugs/DB06027
    Experimental

    NGD-4715 is an investigational compound developed for the treatment of Obesity. NGD-4715 functions as a melanin-concentrating hormone receptor 1 antagonist.

  10. Drug

    OAV201

    go.drugbank.com/drugs/DB17842
    Experimental

    OAV201 is a non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the human Methyl CpG Binding Protein 2B (MECP2B) cDNA under the control of a segment of the murine MECP2 promoter … It was first developed by Novartis and investigated for the treatment of Rett syndrome, but further investigation in clinical trials was halted.[L46661]